Hims & Hers Health, Inc. Reports Second Quarter 2025 Financial Results Revenue of $544.8 million, up 73$42.5 million; Adjusted EBITDA of $82.2 million in Q2 2025 Subscribers grew to over 2.4 million, up 31$2.3 billion to $2.4 billion and Adjusted EBITDA guidance of$295 million to $335 million SAN FRANCISCO, August 4, 2025 – Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), t ...